Inventor · disambiguated record
Shirin Munir
Also filed as: MUNIR SHIRIN
7 granted patents·7 pending applications·3 citations·filing 2016–2024
75Inventor score
Files withUS HEALTH10THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC2SANOFI PASTEUR INC1THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES1
Top patents by PatentIndex Score
14 records- 0190US11591372B2Recombinant human/bovine parainfluenza virus 1 (HPIV1) expressing a chimeric RSV/HPIV1 F protein and uses thereofUS HEALTH·Filed 2020·Granted Feb 28, 2023·2 cites·15 claims
- 0283US12018051B2Recombinant human parainfluenza virus type 1 expressing a chimeric RSV/HPIV1 f protein and uses thereofUS HEALTH·Filed 2023·Granted Jun 25, 2024·0 cites·20 claims
- 0383US2024309053A1Recombinant human/bovine parainfluenza virus 3 (b/hpiv3) expressing a chimeric rsv/piv3 f protein and uses thereofTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2024·Application pending·0 cites
- 0476US2024392317A1Chimeric vectorsTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2024·Application pending·0 cites
- 0575US10654898B2Recombinant human/bovine parainfluenza virus 3 (B/HPIV3) expressing a chimeric RSV/BPIV3 F protein and uses thereofUS HEALTH·Filed 2016·Granted May 19, 2020·1 cites·30 claims
- 0670US2024226118A1Use of ouabain antagonists to inhibit viral infectionUS HEALTH·Filed 2023·Application pending·0 cites
- 0768US11975063B2Recombinant chimeric bovine/human parainfluenza virus 3 expressing rsv g and its useUS HEALTH·Filed 2022·Granted May 7, 2024·0 cites·20 claims
- 0868US11337988B2Use of ouabain antagonists to inhibit viral infectionUS HEALTH·Filed 2019·Granted May 24, 2022·0 cites·15 claims
- 0967US12071632B2Chimeric vectorsUS HEALTH·Filed 2019·Granted Aug 27, 2024·0 cites·19 claims
- 1066US2024415952A1Human metapneumovirus viral vector-based vaccinesSANOFI PASTEUR INC·Filed 2024·Application pending·0 cites
- 1166US2022249518A1Use of ouabain antagonists to inhibit viral infectionUS HEALTH·Filed 2022·Application pending·0 cites
- 1263US2025032603A1Expression of the spike s glycoprotein of sars-cov-2 from avian paramyxovirus type 3 (apmv3)US HEALTH·Filed 2022·Application pending·0 cites
- 1360US11273214B2Recombinant chimeric bovine/human parainfluenza virus 3 expressing RSV G and its useTHE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES·Filed 2018·Granted Mar 15, 2022·0 cites·26 claims
- 1460US2024197861A1Recombinant chimeric bovine/human parainfluenza virus 3 expressing sars-cov-2 spike protein and its useUS HEALTH·Filed 2022·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →